Current Valuation: $4.4 billion (May 2023)

Funding Raised: $1.1 billion

Funding Rounds: 16

No. of investors: 127

Loss: $334 million in FY22

Revenue: $720 million in FY22

Did you know PharmEasy, India’s 45th unicorn, is the first pharmacy delivery platform in India to be certified by the Pharmacy Council of India (PCI)?

An e-commerce platform, PharmEasy offers quality healthcare products and essentials at affordable rates. The company allows users to digitally send prescriptions to drugstores and get medicines delivered to their doorstep.

Founded in 2014 by Dharmil Sheth and Dhaval Shah, the company today extends its supplies to nearly 98% of the Indian pin codes.

Along with establishing PharmEasy, Dharmil is also the co-founder of API Holdings, Ekagrata, and 91streets. An electronics engineer with a BTech degree, he completed his MBA in Marketing from IIM Ghaziabad.

On the other hand, Dhaval is an MBBS from Rajiv Gandhi Government Medical College and completed his MBA from XLRI Jamshedpur. 

The growing digital innovation in India helped PharmEasy strategically align itself as the leading e-pharmacy in the country. With the ease its users were able to order online, PharmEasy found stellar success.

Customers can either access PharmEasy's website or use its mobile app to order items, and the company offers discounts of up to 20% if they order using the mobile app.